Skip to main content

Table 4 Interaction analysis between metabolic syndrome and SNAFLD status on mortality

From: The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females

Subgroup Case Total number HR (95% CI) p value
MetS(−)SNAFLD(−) 62 (12.4) 500 1.000
MetS(+)SNAFLD(−) 49 (31.8) 154 1.845 (1.024–3.323) 0.012*
MetS(−)SNAFLD(+) 21 (30.9) 68 1.910 (1.254–2.908) 0.010*
MetS(+)SNAFLD(+) 23 (54.8) 42 4.958 (2.710–9.071) 0.004*
RERI 2.203 (0.197–4.210)  
AP 0.444 (0.222–0.667)
SI 2.256 (1.252–4.065)
  1. SNAFLD, significant non-alcoholic fatty livers disease, MetS metabolic syndrome
  2. *represent the p value < 0.05. MetS metabolic syndrome, SNAFLD significant non-alcoholic fatty liver disease